Page last updated: 2024-08-23

pyrrolidine and Asthma

pyrrolidine has been researched along with Asthma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aonuma, M; Chiba, J; Iigo, Y; Iimura, S; Machinaga, N; Muro, F; Nakayama, A; Setoguchi, M; Sugimoto, Y; Taira, T; Takashi, T; Takayama, G; Watanabe, T; Yokoyama, M; Yoneda, Y	1

Other Studies

1 other study(ies) available for pyrrolidine and Asthma

Article	Year
A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid. Bioorganic & medicinal chemistry, 2013, Jan-01, Volume: 21, Issue:1 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Asthma; Biological Availability; Bronchi; Cell Line; Cyclohexanecarboxylic Acids; Eosinophils; Female; Haplorhini; Humans; Integrin alpha4beta1; Mice; Mice, Inbred BALB C; Pyrrolidines; Solubility; Water	2013

Article

Year

A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid.

Bioorganic & medicinal chemistry, 2013, Jan-01, Volume: 21, Issue:1

Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Asthma; Biological Availability; Bronchi; Cell Line; Cyclohexanecarboxylic Acids; Eosinophils; Female; Haplorhini; Humans; Integrin alpha4beta1; Mice; Mice, Inbred BALB C; Pyrrolidines; Solubility; Water

2013